 Connection
Gongyi Zhang to Ligands
This is a "connection" page, showing publications Gongyi Zhang has written about Ligands.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.296 |
|
|
|
-
Liu H, Wei P, Aviszus K, Zhang Q, Linderberger J, Yang J, Liu J, Chen Z, Waheed H, Reynoso L, Downey GP, Frankel SK, Kappler JW, Marrack P, Zhang G. The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity. Int J Mol Sci. 2022 Sep 26; 23(19).
Score: 0.160
-
Ning F, Wang C, Berry KZ, Kandasamy P, Liu H, Murphy RC, Voelker DR, Nho CW, Pan CH, Dai S, Niu L, Chu HW, Zhang G. Structural characterization of the pulmonary innate immune protein SPLUNC1 and identification of lipid ligands. FASEB J. 2014 Dec; 28(12):5349-60.
Score: 0.092
-
Zhang G. Tumor necrosis factor family ligand-receptor binding. Curr Opin Struct Biol. 2004 Apr; 14(2):154-60.
Score: 0.044
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|